Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients

Alopecia Universalis (AU) is the most severe form of Alopecia Areata and is caused by cytotoxic T-cells reacting with follicular autoantigens, producing complete loss of scalp and body hair. Alemtuzumab is a highly efficacious monoclonal antibody used in the treatment of Multiple Sclerosis (MS), but...

Descripción completa

Detalles Bibliográficos
Autores principales: Borriello, Giovanna, Ianniello, Antonio, Toosy, Ahmed T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305636/
https://www.ncbi.nlm.nih.gov/pubmed/34299789
http://dx.doi.org/10.3390/ijerph18147338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305636/
https://www.ncbi.nlm.nih.gov/pubmed/34299789
http://dx.doi.org/10.3390/ijerph18147338

Ejemplares similares